ATRA all-trans retinoic acid
Selected indexed studies
- Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. (Eur J Med Chem, 2021) [PMID:33895500]
- All-Trans-Retinoic Acid-Adjuvanted mRNA Vaccine Induces Mucosal Anti-Tumor Immune Responses for Treating Colorectal Cancer. (Adv Sci (Weinh), 2024) [PMID:38528670]
- Post-natal all-trans-retinoic acid biosynthesis. (Methods Enzymol, 2020) [PMID:32359649]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. (2021) pubmed
- All-Trans-Retinoic Acid-Adjuvanted mRNA Vaccine Induces Mucosal Anti-Tumor Immune Responses for Treating Colorectal Cancer. (2024) pubmed
- Post-natal all-trans-retinoic acid biosynthesis. (2020) pubmed
- Retinoic Acid and Its Derivatives in Skin. (2020) pubmed
- Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms. (2023) pubmed
- All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia. (1992) pubmed
- All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma. (2023) pubmed
- All-trans-retinoic acid nanodisks. (2007) pubmed
- Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer. (2023) pubmed
- All-trans retinoic acid beyond acute promyelocytic leukemia. (2025) pubmed